Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chaimae Hafidi Alaoui"'
Autor:
Meryem El azzouzi, Hajar El ahanidi, Chaimae Hafidi Alaoui, Imane Chaoui, Laila Benbacer, Mohamed Tetou, Ilias Hassan, Mounia Bensaid, Mohamed Oukabli, Ahmed Ameur, Abderrahmane Al bouzidi, Mohammed El mzibri, Mohammed Attaleb
Publikováno v:
African Journal of Urology, Vol 28, Iss 1, Pp 1-5 (2022)
Abstract Background The main epigenetic event occurring during the bladder carcinogenesis process is DNA methylation, affecting genes involved in various metabolic pathways and cell regulation. The use of biological fluids such as urine sediments cou
Externí odkaz:
https://doaj.org/article/f8ccc5abace743298ecb4a0d7e0176b0
Autor:
Meryem El Azzouzi, Hajar El Ahanidi, Chaimae Hafidi Alaoui, Imane Chaoui, Laila Benbacer, Mohammed Tetou, Ilias Hassan, Mounia Bensaid, Mohamed Oukabli, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed Attaleb, Mohammed El Mzibri
Publikováno v:
Diagnostics, Vol 13, Iss 8, p 1471 (2023)
Vascular endothelial growth factor (VEGF) and its receptors (VEGFR1 and VEGFR2) are the most important tissue factors involved in tumor growth and angiogenesis. The aim of this study was to evaluate the promoter mutational status of VEGFA and the exp
Externí odkaz:
https://doaj.org/article/23c0fe4bca234622ab69885fb78a41ef
Autor:
Hajar El Ahanidi, Meryem El Azzouzi, Chaimae Hafidi Alaoui, Mohammed Tetou, Mounia Bensaid, Imane Chaoui, Laila Benbacer, Ilias Hassan, Mohamed Oukabli, Katarzyna Michaud, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed El Mzibri, Camilla Jandus, Mohammed Attaleb
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundTumor recurrence and progression in non-muscle invasive bladder cancer (NMIBC), therapy failure, and severe side effects in muscle invasive bladder cancer (MIBC) are the major challenges in the clinical management of bladder cancer (BC). He
Externí odkaz:
https://doaj.org/article/dfc3b6d49c974a3da6194a9af1bd9376
Autor:
Chaimae Hafidi Alaoui, Hajar El Ahanidi, Meryem El Azzouzi, Abdelkarim Filali-Maltouf, Imane Chaoui, Mounia Bensaid, Laila Benbacer, Mohammed Tetou, Ilias Hassan, Mohamed Oukabli, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed Attaleb, Mohammed El Mzibri
Publikováno v:
Annals of Cancer Research and Therapy. 30:1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cd2ec748d762ac1204ed91d35180908
https://doi.org/10.4993/acrt.30.1
https://doi.org/10.4993/acrt.30.1
Autor:
Meryem El Azzouzi, Hajar El Ahanidi, Chaimae Hafidi Alaoui, Imane Chaoui, Laila Benbacer, Mohamed Tetou, Ilias Hassan, Mounia Bensaid, Mohamed Oukabli, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed El Mzibri, Mohammed Attaleb
Publikováno v:
Cancer Genetics. :41-45
Promoter hypermethylation have been reported to play a key role in bladder cancer development and progression. The aim of this study is to evaluate the methylation status of hTERT, TWIST1, VIM and NID2 genes in bladder cancer. The methylation status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff8dbbd4faa5ad15f14a2a1289e4b975
https://doi.org/10.1016/j.cancergen.2021.12.001
https://doi.org/10.1016/j.cancergen.2021.12.001
Autor:
Mohammed ATTALEB, Camilla JANDUS, Mohammed EL MZIBRI, Abderrahmane AL BOUZIDI, Ahmed AMEUR, Katarzyna MICHAUD, Mohamed OUKABLI, Ilias HASSAN, Laila BNBACER, Imane chaoui, Mounia bensaid, Tetou Tetou, Chaimae HAFIDI ALAOUI, Meryem EL AZZOUZI, El Ahanidi Hajar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::773e752913fb73ce6432c3f5e5b4eae1
https://doi.org/10.26226/m.631864567e215f5e7f3852b1
https://doi.org/10.26226/m.631864567e215f5e7f3852b1
AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine
Autor:
Hajar El Ahanidi, Meryem El Azzouzi, Housna Arrouchi, Chaimae Hafidi Alaoui, Mohammed Tetou, Mounia Bensaid, Mohamed Oukabli, Ahmed Ameur, Abderrahmane Al Bouzidi, Mohammed El Mzibri, Mohammed Attaleb
Publikováno v:
Pan African Medical Journal; Vol. 41 No. 1 (2022)
Introduction:in cancer cells, activating mutations in PIK3CA and AKT1 genes, major players of PI3K-AKT-mTOR signalling pathway, are widely reported in many cancers and present attractive targets for the identification of new therapeutics and better c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b2f23415b1f0d8ad3b55971912b2537d
https://pubmed.ncbi.nlm.nih.gov/35317488
https://pubmed.ncbi.nlm.nih.gov/35317488